A Pivotal Phase II/III Clinical Study of Anti-HER2 Bispecific Antibody KN026 Have Met the Primary Endpoint of PFS at Interim Analysis
SUZHOU, China, May 1, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that a phase II/III clinical trial of anti-HER2 bispecific antibody KN026...
Amorepacific Research Confirms Potential of Microalgal-Derived PDRNs in Skin Regeneration and Wound Healing
New findings suggest 'BluePDRN™' offers a sustainable, scalable alternative to traditional animal-derived PDRNs SEOUL, South Korea, April 29, 2025 /PRNewswire/ -- Amorepacific revealed research findings confirming the skin-regenerative effects of...
Antaisolar Shines at Green Energy Expo 2025 in Korea with BIPV and Versatile Mounting Solutions
DAEGU, South Korea, April 28, 2025 /PRNewswire/ -- From April 23 to 25, 2025, Antaisolar made a strong appearance at Green Energy Expo 2025 in Daegu, South Korea, showcasing its latest BIPV systems, rooftop mounting structures, and ground-mounted...
Ascletis Announces Positive Topline Results of U.S. Phase Ib Multiple Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Submission of 13-week Phase IIa Study Protocol to FDA
- ASC30 oral once-daily tablet demonstrated a 6.5% placebo-adjusted mean body weight reduction from baseline after four-week treatment using weekly doses with titrations of 2 mg, 10 mg, 20 mg , and 40 mg doses. - ASC30 oral once-daily tablet also...
SKYWORTH Unveils Revolutionary OmniView Matte Screen, Pushing MiniLED Displays to OLED-Level Performance
SHENZHEN, China, April 22, 2025 /PRNewswire/ -- From April 15 to 19, 2025, SKYWORTH once again took center stage at the 137th China Import and Export Fair (Canton Fair), showcasing its latest breakthroughs in consumer electronics and setting new...
Inspur Communications Information Debuts at the 2025 Hong Kong InnoEX, Empowering the Digital Future
JINAN, China, April 18, 2025 /PRNewswire/ -- The 2025 Hong Kong International Innovation and Technology Exhibition (InnoEX) was grandly held in Hong Kong from April 13 to 16, with the theme "Innovation, Smart Mobility, Taking Off." Inspur...
Caliway Selected to Present CBL-514 Phase 2 Study Results for Dercum's Disease at World Orphan Drug Congress USA 2025
CBL-514, Caliway's novel small molecule drug, was selected for data presentation at the World Orphan Drug Congress USA 2025, highlighting its promising Phase 2 study results (CBL-0201DD) for Dercum's Disease Treatment. The Phase 2 topline results...
Dyna.Ai Unveils Agentic AI Suite - The World's First Multi-Language, Multi-Channel, Multi-Modal AI Agent Platform for Enterprise
SINGAPORE, April 17, 2025 /PRNewswire/ -- Dyna.Ai today announces the global launch of Agentic AI Suite, an enterprise-grade AI platform purpose-built for intelligent, collaborative agents that communicate across multi-language, multi-channel, and...
Montavista lithium metal battery product reaches above 1280 cycles using eVTOL flight profile
FRIEDRICHSHAFEN, Germany, April 14, 2025 /PRNewswire/ -- During the 31st AERO Friedrichshafen aviation exhibition in Germany, Montavista Energy Technologies Corporation (Anhui) (referred to as "Montavista") unveiled the latest cycling performance...
XCMG Crane Showcases Six European-Tailored Models at bauma 2025, Secures Bulk Orders with Sustainable Innovation
MUNICH, April 12, 2025 /PRNewswire/ -- At bauma 2025, the world's leading construction machinery trade fair, XCMG Crane made a resounding statement about its commitment to the European market by unveiling six cutting-edge crane models, engineered...